Robot-assisted Approach to Cervical Cancer
ConditionCervical Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorKarolinska Institutet
About this trial
The purpose of the RACC trial is to compare the oncologic outcome defined as recurrence-free survival (RFS) between robot-assisted and open radical hysterectomy for the treatment of early stage cervical cancer.
Eligibility criteria
Qualifiers
Histologically confirmed primary adenocarcinoma, squamous cell carcinoma or adeno-squamous carcinoma of the uterine cervix;
Patients with histologically confirmed stage IB (IB3 excluded) and IIA1, according to the latest revision of the FIGO staging manual
Patients undergoing either a Type B or C radical hysterectomy (Querleu and Morrow classification)
Patients with adequate bone marrow, renal and hepatic function
Disqualifiers
Any histology other than adenocarcinoma, squamous cell carcinoma or adeno-squamous carcinoma of the uterine cervix
Tumor size greater than 4 cm
FIGO stage II-IV (except IIA1)
Patients with a history of pelvic or abdominal radiotherapy
Trial design
Treatments tested in this trial
- Abdominal radical hysterectomy
- Robot-assisted radical hysterectomy
- Sentinel lymph node biopsy
Treatment groups
800 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov